Belgium· BE-AMP-SAM440307-00
Glypressin 1 mg
A terlipressin product containing terlipressin acetate, registered in Belgium by Ferring. The same ATC class is registered in 15 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Terlipressin is registered in 15 of 19 countries.
Countries holding a registration under ATC H01BA04 (terlipressin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Terlipressin · ATC H01BA04
15 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Terlipressin Acetate
- Manufacturer
- Ferring
- Country
- Belgium (BE)
- ATC code
- H01BA04
- ATC class
- Terlipressin
- Defined daily dose
- 12 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Terlipressin in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenGlypressin 1 mg Injektionsvätska, lösningFerring Läkemedel AB
- CzechiaREMESTYPFerring-Léčiva, a.s., Jesenice u Prahy
- FinlandGlypressinFerring Lääkkeet Oy
- GermanyGlycylpressinFerring Gmbh
- IrelandGLYPRESSIN 1 mg Powder and Solvent for Solution for InjectionFerring Ireland Ltd
- NorwayGlypressinFerring Legemidler AS
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Glycylpressin
- Bulgaria · Реместип
- Germany · Glycylpressin, Terlipressin Aftpharm
- Denmark · Glypressin, Terlipressinacetat Sun
- Estonia · Glypressin
- Spain · Glypressin, Terlipresina Altan
- Finland · Glypressin, Terlipressin Sun
- France · Glypressine, Terlipressine Altan
- United Kingdom (Northern Ireland) · Glypressin, Terlipressin Acetate Aft
- Greece · Glypressin
- Croatia · Glypressin
- Ireland · Glypressin
- Iceland · Glypressin
- Italy · Terlipressina Sun
- Lithuania · Glypressin
- Luxembourg · Glypressin
- Latvia · Glypressin
- Netherlands · Glypressin, Terlipressine Sun
- Norway · Glypressin
- Poland · Glypressin, Terlipressin Acetate Altan
- Portugal · Terlipressina Altan
- Romania · Glypressin
- Sweden · Glypressin, Terlipressin Sun
- Slovenia · Glypressin
- Slovakia · Glypressin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/566d86c5-eed8-4405-8ca1-110255eae9bf GET /v1/drugs/566d86c5-eed8-4405-8ca1-110255eae9bf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Glypressin 1 mg",
"name_fr": "Glypressin 1 mg",
"name_nl": "Glypressin 1 mg",
"amp_code": "SAM440307-00",
"strengths": [
"1.0000",
"0.8500",
"2.3000",
"77.0000"
],
"pack_count": 1,
"substances": [
"Terlipressin Acetate",
"Terlipressin",
"Sodium Acetate Trihydrate",
"Sodium Chloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Terlipressin",
"authorisation_numbers": [
"BE440307"
]
}See everything about terlipressin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.